BCI Marketplace
Depression Neuromodulation trials

Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking

RecruitingNCT07050355Phase: NAStarted 2024-11-01

Summary

Investigators primary aim is to carry out a two-site, randomized, double-blind, sham-controlled, phase II trial to systematically examine the potential for aerobic exercise (AEx) to enhance the anti-depressant benefits of rTMS in individuals with post-stroke depression (PSD). Investigators propose to determine the efficacy of combining two known anti-depressant treatments shown to be effective in non-stroke depression, aerobic exercise (AEx) and repetitive transcranial magnetic stimulation (rTM

Eligibility

Sex
ALL
Min Age
21 Years
Max Age
70 Years

Inclusion Criteria: * age 21-70 * stroke within the past 12 to 60 months * screen positive for probable major depressive disorder (PHQ-9 \> 10) and HAM-D17 ≥ 14 * residual paresis in the lower extremity (Fugl-Meyer LE motor score \<34) * ability to walk without assistance and without an AFO at spee

Locations

Duke University School of Medicine
Durham, North Carolina, United States
Medical University of South Carolina
Charleston, South Carolina, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →